FY2025 Earnings Estimate for Core Laboratories Inc. (NYSE:CLB) Issued By Zacks Research

Core Laboratories Inc. (NYSE:CLBFree Report) – Zacks Research increased their FY2025 earnings per share estimates for Core Laboratories in a research note issued on Tuesday, March 26th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings per share of $0.95 for the year, up from their prior forecast of $0.93. The consensus estimate for Core Laboratories’ current full-year earnings is $0.81 per share.

Several other equities analysts have also commented on CLB. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, January 20th. Stifel Nicolaus lowered their price target on Core Laboratories from $21.00 to $17.00 and set a “hold” rating for the company in a research report on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $19.88.

View Our Latest Analysis on Core Laboratories

Core Laboratories Stock Performance

Shares of Core Laboratories stock opened at $17.00 on Thursday. The company has a current ratio of 2.53, a quick ratio of 1.72 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $796.62 million, a P/E ratio of 19.77, a P/E/G ratio of 0.52 and a beta of 2.39. The business has a fifty day simple moving average of $15.52 and a two-hundred day simple moving average of $18.62. Core Laboratories has a 12 month low of $13.82 and a 12 month high of $27.94.

Core Laboratories (NYSE:CLBGet Free Report) last announced its quarterly earnings results on Wednesday, January 31st. The oil and gas company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.01). Core Laboratories had a return on equity of 15.19% and a net margin of 8.03%. The business had revenue of $128.21 million during the quarter, compared to analysts’ expectations of $127.80 million. During the same period in the previous year, the business earned $0.23 EPS.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 4th. Investors of record on Monday, February 12th were issued a $0.01 dividend. The ex-dividend date of this dividend was Friday, February 9th. This represents a $0.04 annualized dividend and a yield of 0.24%. Core Laboratories’s payout ratio is 4.65%.

Institutional Investors Weigh In On Core Laboratories

A number of large investors have recently made changes to their positions in the company. Allspring Global Investments Holdings LLC purchased a new position in shares of Core Laboratories during the 3rd quarter valued at about $31,000. State of Wyoming lifted its holdings in Core Laboratories by 43.1% in the 2nd quarter. State of Wyoming now owns 1,447 shares of the oil and gas company’s stock worth $34,000 after purchasing an additional 436 shares in the last quarter. Tower Research Capital LLC TRC lifted its holdings in Core Laboratories by 9,913.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,502 shares of the oil and gas company’s stock worth $35,000 after purchasing an additional 1,487 shares in the last quarter. UBS Group AG lifted its holdings in Core Laboratories by 171.6% in the 3rd quarter. UBS Group AG now owns 3,200 shares of the oil and gas company’s stock worth $43,000 after purchasing an additional 2,022 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new position in Core Laboratories in the 4th quarter worth approximately $48,000. 97.81% of the stock is currently owned by institutional investors.

About Core Laboratories

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

Further Reading

Earnings History and Estimates for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.